Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
AMOXICILLINE 3-WATER 91,8 mg/ml SAMENSTELLING overeenkomend met ; AMOXICILLINE 0-WATER 80 mg/ml ; KALIUMCLAVULANAAT 13,6 mg/ml SAMENSTELLING overeenkomend met ; CLAVULAANZUUR 11,4 mg/ml
Devatis GmbH Spitalstrasse 22 795 39 LORRACH (DUITSLAND)
J01CR02
AMOXICILLINE 3-WATER 91,8 mg/ml SAMENSTELLING overeenkomend met ; AMOXICILLINE 0-WATER 80 mg/ml ; KALIUMCLAVULANAAT 13,6 mg/ml SAMENSTELLING overeenkomend met ; CLAVULAANZUUR 11,4 mg/ml
Poeder voor orale suspensie
3-METHYL-1-BUTANOL ; BENZYLALCOHOL (E 1519) ; CELLULOSE, MICROKRISTALLIJN (E 460) ; CITROENZUUR 0-WATER (E 330) ; CROSCARMELLOSE NATRIUM (E 468) ; ETHYLBUTYRAAT ; GLYCEROLTRIACETAAT (E 1518) ; MALTODEXTRINE ; MANNITOL (D-) (E 421) ; MAÏSZETMEEL, GEMODIFICEERD (MODIFICATIE ONBEKEND, (E 1450) ; MIRRE ; PROPYLEENGLYCOL (E 1520) ; SILICIUMDIOXIDE (E 551) ; SILICIUMDIOXIDE, GEHYDRATEERD (E 551) ; SINAASAPPELOLIE ; SUCRALOSE (E 955) ; TRINATRIUMCITRAAT 0-WATER (E 331) ; TUTTI FRUTTI FLAVOR 051880 AP 0551 ; VANILLA FLAVOR 054286 B7P0504 ; VANILLINE ; XANTHAANGOM (E 415),
Oraal gebruik
Amoxicillin and beta-lactamase inhibitor
Hulpstoffen: BENZYLALCOHOL (E 1519); CELLULOSE, MICROKRISTALLIJN (E 460); CITROENZUUR 0-WATER (E 330); CROSCARMELLOSE NATRIUM (E 468); ETHYLBUTYRAAT; GLYCEROLTRIACETAAT (E 1518); MAÏSZETMEEL, GEMODIFICEERD (MODIFICATIE ONBEKEND, (E 1450); MALTODEXTRINE; MANNITOL (D-) (E 421); MIRRE; PROPYLEENGLYCOL (E 1520); SILICIUMDIOXIDE (E 551); SILICIUMDIOXIDE, GEHYDRATEERD (E 551); SINAASAPPELOLIE; SUCRALOSE (E 955); TRINATRIUMCITRAAT 0-WATER (E 331); TUTTI FRUTTI FLAVOR 051880 AP 0551; VANILLA FLAVOR 054286 B7P0504; VANILLINE; XANTHAANGOM (E 415); 3-METHYL-1-BUTANOL;
2016-08-11
1 PACKAGE LEAFLET: INFORMATION FOR THE USER AMOXICILLINE/CLAVULAANZUUR DEVATIS 250 MG/62,5 MG/5 ML POEDER VOOR ORALE SUSPENSIE AMOXICILLINE/CLAVULAANZUUR DEVATIS 400 MG/57 MG/5 ML POEDER VOOR ORALE SUSPENSIE Amoxicillin/clavulanic acid READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START GIVING YOUR CHILD THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR THEM. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine is usually prescribed for a baby or child. Do not pass it on to others. It may harm them, even if their signs of illness are the same as your child’s. - If your child gets any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Amoxicilline/Clavulaanzuur Devatis is and what it is used for 2. What you need to know before you give Amoxicilline/Clavulaanzuur Devatis 3. How to give Amoxicilline/Clavulaanzuur Devatis 4. Possible side effects 5. How to store Amoxicilline/Clavulaanzuur Devatis 6. Contents of the pack and other information 1. WHAT AMOXICILLINE/CLAVULAANZUUR DEVATIS IS AND WHAT IT IS USED FOR Amoxicilline/Clavulaanzuur Devatis is an antibiotic and works by killing bacteria that cause infections. It contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines called “penicillins” that can sometimes be stopped from working (made inactive). The other active component (clavulanic acid) stops this from happening. Amoxicilline/Clavulaanzuur Devatis is used in adults and children to treat the following infections: - middle ear and sinus infections - respiratory tract infections - urinary tract infections - skin and soft tissue infections including dental infections - bone and joint infections. 2. WHAT YOU NEED TO KNOW BEFORE YOU GIVE AMOXICILLINE/CLAVULAANZUUR DEVATIS DO NOT GIVE YOUR CHILD AMOXICILLINE/CLAVULAANZUUR DEVATIS : - if they are al Lees het volledige document
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Amoxicilline/Clavulaanzuur Devatis 250 mg/62,5 mg/5 ml poeder voor orale suspensie Amoxicilline/Clavulaanzuur Devatis 400 mg/57 mg/5 ml poeder voor orale suspensie 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of suspension contains amoxicillin trihydrate equivalent to 50 mg amoxicillin and potassium clavulanate equivalent to 12.5 mg clavulanic acid. 5 ml of suspension contain amoxicillin trihydrate equivalent to 250 mg amoxicillin and potassium clavulanate equivalent to 62.5 mg clavulanic acid. Each ml of suspension contains amoxicillin trihydrate equivalent to 80 mg amoxicillin and potassium clavulanate equivalent to 11.4 mg clavulanic acid. 5 ml of suspension contain amoxicillin trihydrate equivalent to 400 mg amoxicillin and potassium clavulanate equivalent to 57 mg clavulanic acid. Excipients with known effect This medicinal product contains 0.4 mg benzyl alcohol per 5 ml of suspension. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder for oral suspension. White to creamy white powder 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Amoxicilline/Clavulaanzuur Devatis is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1): - Acute bacterial sinusitis (adequately diagnosed) - Acute otitis media - Acute exacerbations of chronic bronchitis (adequately diagnosed) - Community acquired pneumonia - Cystitis - Pyelonephritis - Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis - Bone and joint infections, in particular osteomyelitis. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 2 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component. The dose of Amoxicilline/Clavulaanzuur Devatis that is selec Lees het volledige document